Cabaletta Bio (CABA) Cash & Current Investments (2018 - 2025)

Cabaletta Bio has reported Cash & Current Investments for 8 years, with the latest figure at $133.6 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments fell 18.52% year-over-year to $133.6 million; the trailing twelve-month figure through Dec 2025 stood at $133.6 million (down 18.52% YoY), and the FY2025 full-year result was $133.6 million, down 18.52% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $133.6 million, down from $159.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $272.4 million in Q1 2024, with the low at $93.8 million in Q1 2023.
• Average Cash & Current Investments over 5 years is $161.5 million, with a median of $152.7 million recorded in 2022.
• Year-over-year, Cash & Current Investments soared 190.26% in 2024 and tumbled 51.6% in 2025.
• Tracing CABA's Cash & Current Investments over 5 years: stood at $122.2 million in 2021, then slipped by 12.83% to $106.5 million in 2022, then surged by 126.42% to $241.2 million in 2023, then slumped by 32.04% to $164.0 million in 2024, then retreated by 18.52% to $133.6 million in 2025.
• The last three Cash & Current Investments figures came in at $133.6 million (Q4 2025), $159.9 million (Q3 2025), and $194.7 million (Q2 2025), per Business Quant data.

Peer Comparison